(Q48566487)

12 February 2018

title

Growth-associated protein 43 in lesions and cerebrospinal fluid in multiple sclerosis. (English)

1 reference

12 February 2018

0 references

0 references

6

Vanmechelen E

1 reference

12 February 2018

author name string

Teunissen CE

1

1 reference

12 February 2018

Dijkstra CD

2

1 reference

12 February 2018

Jasperse B

3

1 reference

12 February 2018

Barkhof F

4

1 reference

12 February 2018

Vanderstichele H

5

1 reference

12 February 2018

Polman CH

7

1 reference

12 February 2018

Bö L

8

1 reference

12 February 2018

publication date

1 June 2006

1 reference

12 February 2018

Neuropathology and Applied Neurobiology

published in

1 reference

12 February 2018

volume

32

1 reference

12 February 2018

issue

3

1 reference

12 February 2018

page(s)

318-331

1 reference

12 February 2018

Axonal transection in the lesions of multiple sclerosis

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00730.X

Axonal damage in acute multiple sclerosis lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00730.X

Demyelination and axonal damage in a non-human primate model of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00730.X

Longitudinal brain volume measurement in multiple sclerosis: rate of brain atrophy is independent of the disease subtype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00730.X

Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00730.X

Transection of major histocompatibility complex class I-induced neurites by cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00730.X

Regulation of gene expression in experimental autoimmune encephalomyelitis indicates early neuronal dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00730.X

Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00730.X

Increase of sodium channels in demyelinated lesions of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00730.X

Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00730.X

Cerebral atrophy and disability in relapsing-remitting and secondary progressive multiple sclerosis over four years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00730.X

Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00730.X

Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00730.X

Remodeling of axonal connections contributes to recovery in an animal model of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00730.X

B-50, the growth associated protein-43: modulation of cell morphology and communication in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00730.X

Anti-B-50 (GAP-43) antibodies decrease exocytosis of glutamate in permeated synaptosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00730.X

Absence of persistent spreading, branching, and adhesion in GAP-43-depleted growth cones

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00730.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00730.X

Growth-associated protein GAP-43 in the frontal cortex and in the hippocampus in Alzheimer's disease: an immunohistochemical and quantitative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00730.X

Levels of the growth-associated protein GAP-43 are selectively increased in association cortices in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00730.X

Monoclonal antibodies show that kinase C phosphorylation of GAP-43 during axonogenesis is both spatially and temporally restricted in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00730.X

Immunocytochemical detection of the growth-associated protein B-50 by newly characterized monoclonal antibodies in human brain and muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00730.X

Detection of MHC class II-antigens on macrophages and microglia, but not on astrocytes and endothelia in active multiple sclerosis lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00730.X

Inhibition of axonal growth by SNAP-25 antisense oligonucleotides in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00730.X

Selective regional loss of exocytotic presynaptic vesicle proteins in Alzheimer's disease brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00730.X

Decreased levels of synaptosomal associated protein 25 in the brain of patients with Down syndrome and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00730.X

Analysis of gene expression in mutiple sclerosis lesions using cDNA microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00730.X

GAP-43 overexpression in adult mouse Purkinje cells overrides myelin-derived inhibition of neurite growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00730.X

Spinal axon regeneration evoked by replacing two growth cone proteins in adult neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00730.X

Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00730.X

Myelin-associated inhibitors of axonal regeneration in the adult mammalian CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00730.X

Nerve growth factor controls GAP-43 mRNA stability via the phosphoprotein ARPP-19

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00730.X

Cytokines: powerful regulators of glial cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00730.X

Alternative activation of macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00730.X

Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00730.X

Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00730.X

Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00730.X

Neurotrophins and their receptors: a convergence point for many signalling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00730.X

Myelin inhibitors: does NO mean GO?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00730.X

Treatment with metallothionein prevents demyelination and axonal damage and increases oligodendrocyte precursors and tissue repair during experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00730.X

10.1111/J.1365-2990.2006.00730.X

21 January 2018

Identifiers

DOI

1 reference

12 February 2018

1 reference

12 February 2018